# Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis

> **NCT06441162** · PHASE4 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 75 (actual)

## Conditions studied

- Acute Bronchiolitis

## Interventions

- **DRUG:** Nebulized 3% sodium chloride solution
- **DEVICE:** Chest percussion cups

## Key facts

- **NCT ID:** NCT06441162
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-07-15
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-05-15
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** Study design proved infeasible on the general inpatient pediatrics unit at the investigation site due to uncontrolled variables and protocol non-adherence.
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06441162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06441162, "Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06441162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*